用卡那单抗成功治疗肿瘤坏死因子受体相关周期性综合征。 - Suppr

Suppr

超能文献

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab.

作者信息

Brizi Maria Giuseppina, Galeazzi Mauro, Lucherini Orso Maria, Cantarini Luca, Cimaz Rolando

出版信息

Ann Intern Med. 2012 Jun 19;156(12):907-8. doi: 10.7326/0003-4819-156-12-201206190-00027.

DOI:10.7326/0003-4819-156-12-201206190-00027

PMID:22711098

Abstract

摘要

相似文献

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab.

Ann Intern Med. 2012 Jun 19;156(12):907-8. doi: 10.7326/0003-4819-156-12-201206190-00027.

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

N Engl J Med. 2018 May 17;378(20):1908-1919. doi: 10.1056/NEJMoa1706314.

Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes.

Clin Pharmacol Ther. 2019 Sep;106(3):557-567. doi: 10.1002/cpt.1302. Epub 2019 Jan 28.

"Trap" the diagnosis: a man with recurrent episodes of febrile peritonitis, not just familial Mediterranean fever.

Isr Med Assoc J. 2012 Apr;14(4):229-31.

Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.

Eur J Intern Med. 2024 May;123:156-158. doi: 10.1016/j.ejim.2024.01.034. Epub 2024 Feb 2.

Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Rheumatol Int. 2015 Nov;35(11):1943-7. doi: 10.1007/s00296-015-3305-2. Epub 2015 Jun 6.

Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work?

Intern Emerg Med. 2017 Mar;12(2):269-270. doi: 10.1007/s11739-016-1570-z. Epub 2016 Nov 5.

Canakinumab for the treatment of TNF-receptor associated periodic syndrome.

Expert Rev Clin Immunol. 2017 Jun;13(6):513-523. doi: 10.1080/1744666X.2017.1324783.

Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.

Int J Rheum Dis. 2015 May;18(4):473-5. doi: 10.1111/1756-185X.12521. Epub 2014 Dec 18.

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.

J Allergy Clin Immunol. 2011 Dec;128(6):1352-4. doi: 10.1016/j.jaci.2011.05.023. Epub 2011 Jun 25.

引用本文的文献

Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Am J Clin Dermatol. 2022 Sep;23(5):673-688. doi: 10.1007/s40257-022-00700-4. Epub 2022 May 23.

Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Front Immunol. 2021 Nov 11;12:744780. doi: 10.3389/fimmu.2021.744780. eCollection 2021.

Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.

Int J Mol Sci. 2020 May 5;21(9):3263. doi: 10.3390/ijms21093263.

Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.

Cold Spring Harb Perspect Biol. 2019 Jan 2;11(1):a028563. doi: 10.1101/cshperspect.a028563.

Tumor necrosis factor-associated periodic syndrome in adults.

Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23.

Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.

Front Pharmacol. 2017 May 22;8:278. doi: 10.3389/fphar.2017.00278. eCollection 2017.

Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Clin Rheumatol. 2017 Jul;36(7):1687-1690. doi: 10.1007/s10067-017-3688-4. Epub 2017 May 23.

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.

Front Pharmacol. 2016 Oct 24;7:380. doi: 10.3389/fphar.2016.00380. eCollection 2016.

Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.

Ann Rheum Dis. 2017 Jan;76(1):173-178. doi: 10.1136/annrheumdis-2015-209031. Epub 2016 Jun 7.

Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.

Intern Emerg Med. 2016 Sep;11(6):781-91. doi: 10.1007/s11739-016-1466-y. Epub 2016 May 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验